
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titled "Glenmark Launches Winlevi® (clascoterone) 10 mg/g cream in Key European Markets for the Treatment of Acne Vulgaris".
Filed with NSE · · 4 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titled "Glenmark Launches Winlevi® (clascoterone) 10 mg/g cream in Key European Markets for the Treatment of Acne Vulgaris".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals